CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 14, 2022 · earnings

GRCE earnings: a positive outcome, +7.0%

On February 14, 2022, Grace Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.0% in the window around the event. It had already run -18.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$6.84
1d before
$7.32
Event day
$7.68
1d after
$7.08
5d after

Pre-catalyst setup

-18.0%
30-day run-up
5906%
30-day volatility
0.8×
volume spike